BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9489932)

  • 1. Activation of midline thalamic nuclei by antipsychotic drugs.
    Cohen BM; Wan W; Froimowitz MP; Ennulat DJ; Cherkerzian S; Konieczna H
    Psychopharmacology (Berl); 1998 Jan; 135(1):37-43. PubMed ID: 9489932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action.
    Deutch AY; Ongür D; Duman RS
    Neuroscience; 1995 May; 66(2):337-46. PubMed ID: 7477876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thalamus as a site of action of antipsychotic drugs.
    Cohen BM; Wan W
    Am J Psychiatry; 1996 Jan; 153(1):104-6. PubMed ID: 8540564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
    Wan W; Ennulat DJ; Cohen BM
    Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
    Cohen BM; Cherkerzian S; Ma J; Ye N; Wager C; Lange N
    Psychopharmacology (Berl); 2003 Jun; 167(4):403-10. PubMed ID: 12709776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fos expression induced by olanzapine and risperidone in the central extended amygdala.
    Pinna A; Costa G; Contu L; Morelli M
    Eur J Pharmacol; 2019 Dec; 865():172764. PubMed ID: 31678081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.
    Ma J; Ye N; Lange N; Cohen BM
    Neuroscience; 2003; 121(4):991-8. PubMed ID: 14580949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
    Deutch AY; Duman RS
    Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Neurotox Res; 2008 Oct; 14(2-3):129-40. PubMed ID: 19073421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
    Fujimura M; Hashimoto K; Yamagami K
    Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
    Fujimura M; Hashimoto K; Yamagami K
    Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P; Nomikos GG; Iurlo M; Svensson TH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D
    Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of dopamine release in the bed nucleus of stria terminalis. A trait of atypical antipsychotics?
    Carboni E; Silvagni A; Rolando MT; Di Chiara G
    Ann N Y Acad Sci; 1999 Jun; 877():707-10. PubMed ID: 10415689
    [No Abstract]   [Full Text] [Related]  

  • 18. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
    Porter JH; McCallum SE; Varvel SA; Vann RE
    Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.
    Carboni E; Rolando MT; Silvagni A; Di Chiara G
    Neuropsychopharmacology; 2000 Feb; 22(2):140-7. PubMed ID: 10649827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum.
    Hiroi N; Graybiel AM
    J Comp Neurol; 1996 Oct; 374(1):70-83. PubMed ID: 8891947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.